Related Articles
Brother of regulator of imprinted sites inhibits cisplatin‑induced DNA damage in non‑small cell lung cancer
Medicinal herbs and bioactive compounds overcome the drug resistance to epidermal growth factor receptor inhibitors in non‑small cell lung cancer (Review)
Quinalizarin, a specific CK2 inhibitor, can reduce icotinib resistance in human lung adenocarcinoma cell lines
Tumorigenic effect of <em>TERT</em> and its potential therapeutic target in NSCLC (Review)
Effects of hyperinsulinemia on acquired resistance to epidermal growth factor receptor‑tyrosine kinase inhibitor via the PI3K/AKT pathway in non‑small cell lung cancer cells<em> in vitro</em>